Literature DB >> 6089547

Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers.

M D Hu, D Schenzle, F Deinhardt, R Scheid.   

Abstract

Different population groups from the Shanghai area were surveyed by radioimmunoassay for serologic markers of previous infections with hepatitis A virus and hepatitis B virus. There were no significant differences in the prevalence of antibodies to hepatitis A virus (anti-HAV) in males and females, or in persons living in rural or urban areas. The prevalence of anti-HAV showed a biphasic increase with age, approaching 100% above age 50 years whereas the geometric mean titers declined. The rate of infection (attack rate) with hepatitis A among susceptibles in Shanghai declined appreciably between 1950 and 1960. The prevalence of hepatitis B markers also did not differ in the sexes, or in rural and urban populations. The patterns of prevalence of hepatitis B markers at different ages were compared to various theoretical mathematical models, and the data fitted best a model constructed from the assumption that two subpopulations of approximately equal size, one at low and the other at high risk, existed in the population groups studied. It was estimated that in Shanghai up to 12% of all individuals infected with hepatitis B became chronic hepatitis B surface antigen (HBsAg) carriers, although the overall prevalence of HBsAg carriers was only 6.9%. All HBsAg-positive individuals subtyped had been infected with hepatitis B virus of the subtype ad; 41.7% of HBsAg carriers also had hepatitis B e antigen (HBeAg), whereas in 32% of HBsAg carriers antibodies to HBe were present. Antibodies to HBsAg appeared to be lower in titer than in Western populations and to decline with age, and age-specific prevalence data indicated a relatively longer persistence of antibodies to hepatitis B core antigen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089547     DOI: 10.1093/oxfordjournals.aje.a113905

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  4 in total

1.  The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients.

Authors:  K A Al-Mekhaizeem; M Miriello; A H Sherker
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

2.  Prevalence of HBeAg, anti-HBe serological markers and HBV-DNA in asymptomatic carriers in Ethiopia.

Authors:  M Rapicetta; K Hailù; G Morace; L Bisanti; A M Di Rienzo; A R Ciccaglione; D Bekura; P Pasquini; G B Rossi
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

Review 3.  Update on diagnosis, management, and prevention of hepatitis B virus infection.

Authors:  F J Mahoney
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Hepatitis B virus among Saudi children in Gizan, Saudi Arabia.

Authors:  C M Parande; S C Arya; S J Ashraf
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.